Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Réglementation et droit · 20/09/20021 min de lecture
Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Compositions for Treatment of Hemorrhaging With Activated Factor VIIa in Combination With Fibrinogen and Methods of Using Same
Traduction automatique locale · Langue originale de la source
Résumé
In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of U.S. Patent Application No. 09/756,907 entitled "Compositions for Treatment of Hemorrhaging with Activated Factor VIIa in Combination with Fibrinogen and Methods of Using Same," filed January 10, 2001. Foreign rights (PCT/US01/00725) are also available. The United States Government, as represented by the Secretary of the Army has rights in this invention.
Langue originale de la source: Federal Register — All DocumentsOuvrir le communiqué original →